Characterization of a second vaccinia virus mRNA-decapping enzyme conserved in poxviruses.
about
Multiple mRNA decapping enzymes in mammalian cellsStress Beyond Translation: Poxviruses and MoreThe master regulator of the cellular stress response (HSF1) is critical for orthopoxvirus infectionActivation of host translational control pathways by a viral developmental switchRegulation of host translational machinery by African swine fever virus.Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencingMolecular characterization of a novel mycovirus in the cultivated mushroom, Lentinula edodes.Characterization of the vaccinia virus D10 decapping enzyme provides evidence for a two-metal-ion mechanism.Strategies for viral RNA stability: live long and prosperPoxvirus decapping enzymes enhance virulence by preventing the accumulation of dsRNA and the induction of innate antiviral responsesCleavage of Dicer protein by I7 protease during vaccinia virus infection.Inhibition of Translation Initiation by Protein 169: A Vaccinia Virus Strategy to Suppress Innate and Adaptive Immunity and Alter Virus Virulence.Poly(A) binding protein abundance regulates eukaryotic translation initiation factor 4F assembly in human cytomegalovirus-infected cells.The African swine fever virus g5R protein possesses mRNA decapping activity.Eukaryotic translation initiation factor 4F architectural alterations accompany translation initiation factor redistribution in poxvirus-infected cellsInterplay between viruses and host mRNA degradationOpposing Roles of Double-Stranded RNA Effector Pathways and Viral Defense Proteins Revealed with CRISPR-Cas9 Knockout Cell Lines and Vaccinia Virus MutantsPredicted poxvirus FEN1-like nuclease required for homologous recombination, double-strand break repair and full-size genome formation.The D10 decapping enzyme of vaccinia virus contributes to decay of cellular and viral mRNAs and to virulence in miceInvestigating Viruses during the Transformation of Molecular Biology.Tinkering with translation: protein synthesis in virus-infected cells.DNA virus replication compartments.Vaccinia virus inhibits NF-κB-dependent gene expression downstream of p65 translocation.Emerging roles for RNA degradation in viral replication and antiviral defense.Diverse mechanisms evolved by DNA viruses to inhibit early host defenses.Golgi anti-apoptotic protein: a tale of camels, calcium, channels and cancerMyxoma Virus Induces Ligand Independent Extrinsic Apoptosis in Human Myeloma CellsCellular 5'-3' mRNA exonuclease Xrn1 controls double-stranded RNA accumulation and anti-viral responses.The 5'-poly(A) leader of poxvirus mRNA confers a translational advantage that can be achieved in cells with impaired cap-dependent translation.Nuclease escape elements protect messenger RNA against cleavage by multiple viral endonucleases.Going against the Tide: Selective Cellular Protein Synthesis during Virally Induced Host Shutoff.Ribosome Profiling Reveals Translational Upregulation of Cellular Oxidative Phosphorylation mRNAs during Vaccinia Virus-Induced Host Shutoff.Insights into the molecular determinants involved in cap recognition by the vaccinia virus D10 decapping enzyme.Characterization of the African swine fever virus decapping enzyme during infection.Evolutionary clash between myxoma virus and rabbit PKR in Australia.The Battle of RNA Synthesis: Virus versus Host.Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory.Vaccinia Virus C9 Ankyrin Repeat/F-Box Protein Is a Newly Identified Antagonist of the Type I Interferon-Induced Antiviral State.Targeting Poxvirus Decapping Enzymes and mRNA Decay to Generate an Effective Oncolytic Virus.Viral manipulation of host mRNA decay.
P2860
Q24306739-58FCE8DA-4FE1-4D26-8F2A-41AC22BB7646Q26744471-051F7439-BA0B-4E34-B363-8E30E3ACA2E3Q28539622-5AEE00B3-B7D0-415D-84E8-786FEE458D0DQ33419826-DAD4647E-528A-45D2-81BA-AB9B3F436341Q33497920-26966209-DF27-41A8-950E-F9EF9AA54439Q33953053-F3984B2E-A4F9-42F1-8575-A20B9CA9BD80Q34184984-E5C307D1-D97C-430F-8D90-A91FEB51C3E5Q34942694-57190531-AEA3-4933-86CE-6818D4A0985DQ35069751-B6CC97D2-D46E-452E-B432-5B82C5AC24BFQ35177770-ED86ACEB-FF01-4271-A873-D8DBCABFA863Q35225008-0959695B-4BE4-4A86-9DD6-9BD1E692F0E8Q35763016-83B3A495-74F3-427E-AC95-F530F20F7BB6Q35889417-FE93644A-010D-41A2-9630-F6FEFAD0CE46Q36082826-0B68AB7E-F142-4503-8164-F41AC1DBE00DQ36540315-A1ED041C-0227-4F3C-B270-A4837B6481A7Q36785197-5A5A0D8C-C65C-4F54-802D-107BA58EA662Q37182678-DD8D7ED6-388C-4F8F-A099-C681EE5404E7Q37371038-D766C23B-D098-4CBE-9352-E645FDA1979FQ37547637-F5F702B8-D4F0-4157-9B90-CFEEAB6D2E09Q37705604-5AC56C48-1FD1-48C2-959D-3102332B4566Q38064834-9AAFED52-1EF3-4F5C-ADC4-4E845850C4C7Q38164528-6698791E-97DA-4448-995F-1E602C2E871AQ38326055-8BA4D4D1-150B-4F55-8325-59A05695BC4AQ38365673-11559C20-C07C-4949-BB22-14C104A81194Q38960064-5F189E4A-1409-4F7E-B8BC-A67F6431FFB8Q39281472-91CE0AED-2A4C-40F4-927F-DFA2EA85A049Q39633869-924B1DB5-6610-4F1A-9E24-50B0858A7FD0Q40000006-9AA11215-CBB1-4F29-9832-2404ACE58017Q40064979-4F50DD4A-B5A8-4F7E-9749-67B17DB3B2E2Q40070266-37F2239F-77F5-46BD-AD37-EEF01F51D8D2Q40150622-3EC12449-969A-4347-9FE1-7957C80F6F83Q40399879-3DAE523B-0A84-41D7-9F95-12A76756F7A6Q41352122-96368683-8DC4-478D-9B9B-5689436B7132Q41918732-5F413632-61DD-4D7B-9A9A-4C6420001743Q42870461-111B4732-DD27-4029-9254-53D9DAD5A219Q45325752-18926D79-BFD2-4F80-879D-F669E2F2A460Q50533334-5D776939-5006-4E4E-9FBA-18940E8DABD3Q52378707-4A6E62F9-8B97-474E-947C-D13B1B41C95DQ55051893-79C47611-B6C2-4A55-BECF-8E7A04C61819Q55313246-FB922C48-A318-420F-B2C1-BB9CF371FED8
P2860
Characterization of a second vaccinia virus mRNA-decapping enzyme conserved in poxviruses.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Characterization of a second v ...... nzyme conserved in poxviruses.
@ast
Characterization of a second v ...... nzyme conserved in poxviruses.
@en
Characterization of a second v ...... nzyme conserved in poxviruses.
@nl
type
label
Characterization of a second v ...... nzyme conserved in poxviruses.
@ast
Characterization of a second v ...... nzyme conserved in poxviruses.
@en
Characterization of a second v ...... nzyme conserved in poxviruses.
@nl
prefLabel
Characterization of a second v ...... nzyme conserved in poxviruses.
@ast
Characterization of a second v ...... nzyme conserved in poxviruses.
@en
Characterization of a second v ...... nzyme conserved in poxviruses.
@nl
P2860
P356
P1433
P1476
Characterization of a second v ...... nzyme conserved in poxviruses.
@en
P2093
Susan Parrish
P2860
P304
12973-12978
P356
10.1128/JVI.01668-07
P407
P50
P577
2007-09-19T00:00:00Z